Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

NCT03744663 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Funding for uninsured subjects could not be realized and staffing after COVID hit was also a problem.

Conditions

Interventions

Sponsor

Wake Forest University Health Sciences